Abrard, Stanislas
Streichenberger, Antoine
Riou, Jérémie
Hersant, Jeanne
Rineau, Emmanuel
Jacquet-Lagrèze, Matthias
Fouquet, Olivier
Henni, Samir
Rimmelé, Thomas
Article History
Received: 7 May 2023
Accepted: 13 February 2024
First Online: 29 February 2024
Declarations
:
: The protocol was approved by the institutional review board of <i>Ile de France 1</i> (CPP IDF1, Paris, France) on October 10, 2018 (Ethics Committee No. 2018-A2341-54) and registered at ClinicalTrials.gov (NCT03631797). A signed informed consent was obtained from each patient.
: Not applicable.
: The authors declare no competing interests.